南模生物(688265.SH):目前海外業務佈局仍以BD為主
格隆匯2月2日丨南模生物(688265.SH)近期在接待機構投資者調研時表示,目前,海外業務佈局仍以BD為主,公司會持續擴充海外BD團隊,尤其是加大在波士頓、加州等生物醫藥發達地區的BD招聘和培訓,加大海外市場拓展力度,希望持續提升海外收入增速及佔比。
另外,美國子公司已在美國得克薩斯州購置房產,結合目前市場需求情況及產能擴張帶來的投入影響,暫時未進行裝修投入,海外租賃部分籠位可以滿足當前需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.